American Diabetes Association (ADA): 2024 Pathway to Stop Diabetes - Initiator Award (INI) & Accelerator Award (ACE)
Submit ticket request // Limit: 2* // Tickets Available: 2
Starting in 2024, ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research.
Pathway to Stop Diabetes has a simple, yet revolutionary goal: to find scientists at the peak of their creativity and provide them with the flexibility and resources they need on the road to breakthrough discoveries. We attract and retain brilliant scientists in diabetes. Our three areas of focus—awarding research grants, providing access to scientific and career mentoring from leading diabetes researchers, and creating a diabetes think tank—are each key components of a unique formula to cultivate the next generation of leaders, whose discoveries will stop diabetes and all of its burdens once and for all.
Initiator Award (INI)
- Award Term: Up to 7 years
- Applicant: Postdoctoral Fellow
- Maximum Funding: Up to $100,000/year in Phase 1, Up to $325,000/year in Phase 2
- Support: Project support & PI salary
- Indirect Support: Up to 10% of directs in Phase 1, Up to 30% of directs in Phase 2
- Project % Effort Required: 75-100% effort in Phase 1, 50-75% effort in Phase 2
- Citizenship: Authorized to work in U.S. or U.S. possessions
- Description: This two-phased award is designed to support the transition of scientists from mentored training to independent research faculty.
- Eligibility: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
- Support: Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.
Accelerator Award (ACE)
- Award Term: Up to 5 years
- Applicant: Early Career Faculty
- Maximum Funding: $325,000/year
- Support: Project support & PI salary
- Indirect Support: Up to 30% of directs
- Project % Effort Required: 25-50% effort
- Citizenship: Authorized to work in U.S. or U.S. possessions
- Description: This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs.
- Eligibility: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
- Support: Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.